Six years ago, Eli started with a bold idea: what if you could measure hormones in real-time—no lab, no delays, no barriers?
Today, we’re proud to share a major milestone: we’ve raised $12M in Series A funding to scale that vision. The round was led by BDC Capital’s Thrive Venture Fund, with participation from Muse Capital, TELUS Global Ventures, and other investors who share our belief that hormone health is the next frontier in personalized care. This brings our total funding to $20M, and it’s helping us bring the Hormometer™—the world’s first instant hormone monitoring system—to millions.
The Context
Hormones power nearly everything: stress, energy, and recovery; mood, focus, and sleep; fertility, performance, and longevity. And yet most of us have no idea what our hormones are doing. We’re flying blind.
Traditional testing is built for snapshots—a single point in time, captured in a lab, days or weeks after symptoms show up. But hormones shift constantly. Cortisol, for example, can fluctuate 100% in an hour. One-time tests can help, but they miss the bigger picture. What we need is a live feed.
The Problem
Hormone imbalances are widespread, underdiagnosed, and often addressed only after years of symptoms. The data makes that clear:
-
1 in 3 adults show signs of cortisol dysregulation
-
60% of adults will experience symptoms related to hormone imbalances
Despite how common these issues are, the tools to understand our hormones in real time haven’t existed. Until now.
The Solution
We built what was missing: a way to track hormones instantly using just saliva and your phone.
Introducing the Hormometer™—the first real-time hormone monitor. No labs. No sample shipments. No waiting. Just results, in minutes, from saliva to your phone.
With continuous tracking, you don’t just get a number. You get context. This is a new layer of digital health intelligence—a live view of your biology that helps you understand what’s happening now and take action.
Behind the Scenes
Eli isn’t just a consumer health brand. We’ve built deep technology to build the real-time interface to the human body and to make instant hormone monitoring possible—end to end. That includes:
-
Biochemistry designed for microfluidics
-
AI and machine learning to interpret dynamic hormone signals
-
Custom hardware, manufactured in-house
-
12+ patent-pending innovations across science, engineering, and design
After years of R&D, we’ve reached commercial readiness. We’ve completed third-party validations. And our private beta is live, with early adopters already using the Hormometer™ as part of their health routines.
What’s Next
This fundraise helps us run even faster: scaling production, expanding access, and unlocking more biomarkers—starting with cortisol and progesterone. We’re building toward a public launch later this year.
If you want early access, you can request it here.
To our community, our partners, and our investors: thank you for believing in what’s possible. This is just the beginning.
Read more about the fundraise at Axios, Fitt Insider, Femtech Insider, BetaKit, and Athletec News.
